Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/79796
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Andrew, N. | - |
dc.contributor.author | Kearney, D. | - |
dc.contributor.author | Selva-Nayagam, D. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Eye, 2013; 27(4):561-563 | - |
dc.identifier.issn | 0950-222X | - |
dc.identifier.issn | 1476-5454 | - |
dc.identifier.uri | http://hdl.handle.net/2440/79796 | - |
dc.description.abstract | PURPOSE The purpose of this study is to assess the utility of intraorbital injection of triamcinolone acetonide as a primary treatment option for orbital reactive lymphoid hyperplasia (RLH). PATIENTS AND METHOD Retrospective, single-centre, interventional case series. RESULTS Intraorbital injection of triamcinolone acetonide was associated with complete resolution of all symptoms and signs in four cases (80%). This was achieved with a single injection in two cases and with two injections in another two cases. Radiological resolution was confirmed in one case. One case developed bilateral multifocal orbital RLH lesions 1 month after the second injection. CONCLUSION Intraorbital injection of corticosteroid may be a useful treatment option for orbital RLH, and may have a role as a first-line therapy in RLH of the anterior orbit. A significant proportion of patients may require repeat injections to achieve resolution. A larger prospective study is required to validate our findings. | - |
dc.description.statementofresponsibility | NH Andrew, D Kearney and D Selva | - |
dc.language.iso | en | - |
dc.publisher | Nature Publishing Group | - |
dc.rights | © 2013 Macmillan Publishers Limited All rights reserved | - |
dc.source.uri | http://dx.doi.org/10.1038/eye.2012.288 | - |
dc.subject | reactive lymphoid hyperplasia | - |
dc.subject | lymphoproliferative disorders | - |
dc.subject | corticosteroid | - |
dc.subject | drug therapy | - |
dc.subject | orbital disease | - |
dc.title | Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1038/eye.2012.288 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Selva-Nayagam, D. [0000-0002-2169-5417] | - |
Appears in Collections: | Aurora harvest 4 Opthalmology & Visual Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.